Mar, 24 2026

Post-Market Studies on Generic Drug Safety: What Happens After Approval

Generic drugs save money, but they aren't tested the same way as brand-name drugs before approval. Post-market studies and clinical follow-up are critical to catch hidden safety issues that only appear after millions of people start using them.

Read More

Mar, 1 2026

Identifying Problem Generics: When Pharmacists Should Flag Issues

Generics save billions, but not all are safe. Pharmacists must know when to flag problematic versions - especially for NTI drugs, complex formulations, or after manufacturer switches. Here’s how to spot the risks and act.

Read More